13F

Stock

BridgeBio Pharma, Inc.

BBIO · held by 19 managers

Reported value

$595.7M

Holders

19

+4 new · −0 exited

Holders’ est. mark

$395.2K

Price effect on 4 books still in the name

Largest holder

$425.5M

FARALLON CAPITAL MANAGEMENT LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
FARALLON CAPITAL MANAGEMENT LLC8.19M$425.5MNew
BANK OF AMERICA CORP /DE/3.71M$75MHeld
MORGAN STANLEY2.67M$56.4MHeld
BARCLAYS PLC861.4K$37.5M$317.7KCut−$2.79M
Henshaw Capital LLC13K$677.1K$72.3KAdded$320.6K
Swiss Life Asset Management Ltd6.67K$346.2KNew
Leonteq Securities AG4.09K$212.6K$2.49KAdded$200.4K
IFP Advisors, Inc347$18KHeld
Allworth Financial LP317$16.5KHeld
Essential Partners LLC305$15.8K$2.67KAdded$2.67K
Painted Porch Advisors LLC200$10.4KHeld
KBC Group NV4.2K$218Held
Principia Wealth Advisory, LLC2$104Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.